IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Stock Profile — Insider Trades & Financials

Revenue$86.8M

Net Income-$71.9M

EPS$-1.09

Market Cap$1.7B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Frederick Vogt

CEO & Executive Director

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

Founded: 2007
Employees: 319
Headquarters: SAN CARLOS, CA, United States
Website: www.iovance.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-10.29%

ROA?

-7.87%

D/E Ratio?

0.31

Op. Margin?

-84.66%

📊

Profitability Ratios

Net Margin?

-82.87%

Loading company sections...

IOVANCE BIOTHERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

The morning brief, before the bell.

IOVANCE BIOTHERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades